ArticleBiomedicines2021

Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet-Activating Factor and Its Precursors: A Combined Metabolomic and Lipidomic Approach.

Alessandro Di Minno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.